VIM
ASND icon

Vinva Investment Management’s Ascendis Pharma A/S ASND Stock Holding History

Vinva Investment Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Sell
4,536
-1,158
-20% -$271K 0.01% 304
2026
Q1 		$1.81M Buy
+5,694
New +$1.28M 0.02% 292

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vinva Investment Management's ASND Position: Q2 2026 in Review

Vinva Investment Management reduced its Ascendis Pharma A/S (ASND) stake by 20% in Q2 2026, selling an estimated $271K and leaving 4,536 shares worth $1.74M. The position accounts for 0.01% of the portfolio, ranked #304.

Vinva Investment Management first reported a position in ASND in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.81M in Q1 2026. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Vinva Investment Management held 4,536 shares of Ascendis Pharma A/S worth $1.74M as of Q2 2026.
  • Vinva Investment Management sold 1,158 Ascendis Pharma A/S shares in Q2 2026, an estimated $271K.
  • Ascendis Pharma A/S made up 0.01% of Vinva Investment Management's portfolio in Q2 2026, its #304 holding.
  • Vinva Investment Management first reported a position in Ascendis Pharma A/S in Q1 2026 and has held it in 2 quarters since.
  • Vinva Investment Management's Ascendis Pharma A/S position peaked at $1.81M in Q1 2026.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.